SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-045420
Filing Date
2019-08-13
Accepted
2019-08-13 07:12:59
Documents
51
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-12910_110q.htm 10-Q 1247091
2 EX-31.1 a19-12910_1ex31d1.htm EX-31.1 13287
3 EX-31.2 a19-12910_1ex31d2.htm EX-31.2 13288
4 EX-32.1 a19-12910_1ex32d1.htm EX-32.1 7704
  Complete submission text file 0001104659-19-045420.txt   4556518

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mist-20190630.xml EX-101.INS 898480
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mist-20190630.xsd EX-101.SCH 34164
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mist-20190630_cal.xml EX-101.CAL 38482
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mist-20190630_def.xml EX-101.DEF 148236
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT mist-20190630_lab.xml EX-101.LAB 321254
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mist-20190630_pre.xml EX-101.PRE 249936
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 191018229
SIC: 2834 Pharmaceutical Preparations